AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

HYFT

MindWalk·NASDAQ
--
--(--)
--
--(--)

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About HYFT

Mindwalk Holdings Corp.

A"bio native AI"platform company transforming from wet experimental services

Biotechnology Ⅲ
11/22/1983
12/30/2020
NASDAQ Stock Exchange
74
04-30
Common stock
Industrious 823 Congress Ave Suite 300 Austin, Texas 78701, United States
Conducts AI-driven biotherapeutic research and develops drug discovery technologies.
MindWalk Holdings Corp. was incorporated under the laws of Alberta on November 22, 1983 and expanded to British Columbia on September 2, 2016. On December 21, 2016, the company changed its name to "Immunoprecise Antibodies Ltd.". The company is an innovation-driven technology platform company dedicated to supporting its pharmaceutical and biotechnology company partners to discover and develop novel therapeutic antibodies against various disease targets. The company aims to revolutionize the traditional multi-supplier product development model by providing innovative and high-throughput technologies to partners. The company combines the advantages of a diversified antibody library with its own therapeutic antibody discovery technology to develop antibodies with broad epitope coverage, multiple antibody forms, valence states and sizes, and discover antibodies against multiple/rare epitopes.

Company Financials

EPS

HYFT has released its 2026 Q2 earnings. EPS was reported at -0.05, versus the expected -0.04, missing expectations. The chart below visualizes how HYFT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

HYFT has released its 2026 Q4 earnings report, with revenue of 3.02M, reflecting a YoY change of 51.96%, and net profit of -2.84M, showing a YoY change of -81.43%. The Sankey diagram below clearly presents HYFT's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data